This page includes the latest FDA filings for Halo Pharmaceutical Canada Inc A Subsidiary Of Cambrex Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2023-12-15 |
TruPharma LLC, Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-10-27 |
Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-10-27 |
Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-04-01 |
TruPharma LLC, Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-03-29 |
Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-03-29 |
Tasman Pharma Inc., Halo Pharmaceutical Canada Inc., a subsidiary of Cambrex Corporation., Douglas Pharma US Inc. | Prescription Medication | 2022-03-03 |